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Introduction
The clinical meaning of acute malapposition 
and of the presence of struts detached from the 
coronary wall is still unclear. It has been dem-
onstrated that the healing process of jailing and 
malapposed struts is delayed with respect to 
well-apposed ones [1, 2]. Moreover, the risk of 
malapposed struts to remain uncovered is directly 
proportional to the magnitude of the detachment: 
the further the strut from the vessel wall, the 
more likely to remain uncovered [2], the most 
severe the fluid disturbances induced [3] and the 
higher the shear stress rate on the strut surface, 
that might have a prothrombotic effect [3]. None-
theless there is no compelling evidence hitherto 
linking these pathophysiologic and biomechanical 
phenomena in malapposed and jailing struts with 
an adverse clinical outcome, namely with a higher 
incidence of thrombotic events, therefore the ques-
tion about how far the stent optimisation should 
be driven remains open. Hereby we are reporting 
to the best of our knowledge the first case of very 
late stent thrombosis (VLST) most likely due to 
suboptimal stent deployment and the subsequent 
disturbances in coronary flow and biomechanics, 
exhibiting some differential features as compared 
with VLST in other anatomic scenarios [4–6], thus 
strongly suggesting a differentiated pathophysi-
ologic mechanism.
Case report
A 64-year-old female patient, smoker, was ad-
mitted to the emergency room for recurrent chest 
pain during the last 12 h. Drug-eluting stents (DES) 
had been implanted in the proximal left anterior 
descending artery (LAD) (> 100 months ago) and 
in the ostial left circumflex artery (LCx) (31 months 
ago) according to an external report, but no more 
information was available. The electrocardiogram 
showed negative T waves in precordial leads and 
serum cardiac markers were elevated. Notwith-
standing optimal medical treatment for non-ST-
-elevation myocardial infarction, intermittent and 
recurrent episodes of angina prompted an urgent 
coronary angiography 90 min after admission, that 
unravelled a waving intraluminal filling defect in 
the proximal LAD (Fig. 1; Video 1 — see journal 
website, supplementary file). 
Optical  coherence tomography (OCT) 
showed a stent in the proximal LAD, covered by 
a homogeneous and regular layer, highly sugges-
tive of neointima (Fig. 2A; Video 2 — see jour-
nal website, supplementary file), whilst the 
stent in the ostial LCx extended to the left main 
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artery (LM), thus jailing the ostium of the LAD 
(Fig. 2; Video 2 — see journal website, sup-
plementary file). A red thrombus was attached 
to the jailing struts (Fig. 2D–E, red arrows) and 
prolapsed into the LAD (Fig. 2A–C, red arrows). 
Aided by strut-automatic-detection software, 
the longitudinal OCT view (Fig. 3) and the three-
dimensional (3D)-OCT image fusion (Fig. 4) 
rendered characteristic stent platform patterns 
of the previously implanted DES, which could 
Figure 1. Coronary angiography, right anterior oblique caudal projection, showing a waving intraluminal filling defect 
in the proximal left anterior descending artery (Video 1 — see journal website, supplementary file).
Figure 2. Optical coherence tomography cross-sections, showing a red thrombus (A–E, red arrows), attached to the 
jailing struts (D, E) and floating in the left anterior descending artery (LAD) (A–C). The stent in the left circumflex artery 
(LCx) extends to the left main artery (LM), jailing the ostium of the LAD (D–F). Its proximal part is crushed against the 
LM wall, showing a double metallic layer on one sector, whilst no metallic layer in the opposite sectors (G–I).
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be thus identified as a Taxus Liberté (proximal 
LAD) and a Xience (ostial LCx-LM). The proxi-
mal part of the thrombosed Xience was crushed 
against the wall of the LM, as depicted by the 
double metallic layer of struts on one sector of 
the vessel, whilst no layer could be seen on the 
opposite sector (Fig. 2G–I). The angiographically 
unapparent stent crushing in the distal left main 
is most clearly recognisable at first glance in the 
longitudinal view (Fig. 3), particularly the lower 
panel (Fig. 3B), and in the 3D-OCT image fusion 
(Fig. 4). The 3D-OCT image fusion shows in full 
detail the anchoring of the thrombus to the non-
apposed jailing struts of the Xience stent (Fig. 4, 
red arrows). The thrombus aspirate showed 
a predominantly red thrombus with very scarce 
presence of neutrophils (Fig. 5).
A 3 × 12 everolimus-eluting stent was im-
planted in the LAD-LM, with simultaneous kissing-
balloon inflation and final POT-technique (proximal 
optimisation technique) in the LM, thus transform-
ing the initially irregular situation of the deformed 
stent into a mix of reverse-culotte (distally) and 
crush (proximally), which are biomechanically 
more predictable scenarios, with an excellent re-
sult. No jailing struts can be identified in the final 
OCT pullback, and malapposition was minimised 
(Video 3 — see journal website, supplemen-
tary file).
Figure 3. Optical coherence tomography longitudinal views at different rotation positions. The automatic strut detec-
tion permits to identify the typical stent platform patterns of a Taxus Liberté (proximal LAD) and a Xience (LCx-LM). 
A red thrombus (arrows) is attached to the jailing struts of the Xience stent (A, B), which is crushed against the wall 
of the left main in its proximal part (B).
Figure 4. Optical coherence tomography image fusion, 
rendering the vessel as three-dimensional, at different 
rotation positions. The automatic strut detection permits 
to identify the typical stent platform patterns of a Taxus 
Liberté (proximal LAD) and a Xience (LCx–LM). A red 
thrombus (arrows) is attached to the jailing struts of the 
Xience stent, which is crushed against the wall of the left 
main in its proximal part.
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Discussion
Two main pathophysiologic mechanisms of 
VLST have been described hitherto, namely neo-
atherosclerosis and vascular toxicity/hypersensi-
tivity vasculitis [7]. Nonetheless both substrates 
can be reasonably ruled out in the current case after 
OCT imaging, because no cross-section presents 
lipid-rich or calcified neointima, thus discarding 
neoatherosclerosis, or any direct or indirect sign 
of positive remodeling or late-acquired malappo-
sition, thus discarding vascular toxicity as well. 
Our case describes however an alternative and 
plausible mechanism to explain the pathogenesis 
of the thrombus. Albeit inadvertent in the coronary 
angiography, the OCT imaging unravels a poorly 
implanted stent in the LCx, extending up to the LM 
and crushed against the LM wall, probably due to 
accidental abluminal wiring during the implanta-
tion. The stent structure is severely distorted, 
leaving a double metallic layer that jails the ostium 
of the LAD and poses a substrate of gross malap-
position in the LM. These scenario is a known 
predisposing factor for thrombotic complications, at 
least theoretically, because it entails higher risk of 
Figure 5. Pathology of the thrombus. The thrombus was harvested by means of aspiration thrombectomy (A). The 
Elastica-van-Gieson’s staining confirms the presence of fibrin and red cells, together with absence of collagen, elastic 
fibres and elements proper of the vessel wall (B). Haematoxylin-eosin staining shows a red thrombus, as previously 
depicted in optical coherence tomography, with scarce and predominantly neutrophilic infiltrates (C, D).
delayed healing [1, 2], alters severely the coronary 
flow and induces high shear stress rates at the 
metallic surface of some struts, that might acti-
vate the platelets and the coagulation cascade [3]. 
Therefore, having reasonably ruled out other 
causes of VLST, we can carefully claim that the 
most likely and most plausible mechanism for the 
thrombosis in this case are the flow disturbances 
induced by the gross malapposition and the jailing 
struts of the suboptimally implanted stent in the 
LCx. As additional evidence supporting this mecha-
nism, the OCT has clearly identified the anchoring 
point of the thrombus in the centre of the metallic 
mesh jailing the ostium of the LAD, which is the 
region where the neointimal coverage should be 
poorest [2] and the shear stress rate highest [3] 
according to previous studies, therefore where the 
thrombotic diathesis should be highest according 
to the predictions of the shear stress model of 
flow disturbances induced by detached struts. To 
the best of our knowledge this is the first report 
linking so clearly a case of VLST with predispos-
ing mechanical factors in a poorly implanted stent. 
Our paradigmatic case complements previous 
case series of VLST, studied in full detail with 
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invasive imaging and histopathologic analysis of 
the thrombus, in which this association could not 
be demonstrated [7].
The histopathology of the thrombus sug-
gests also a differentiated pathogenesis from 
that described in cases of vascular toxicity or 
vasculitis. Delayed hypersensitivity reactions 
recruiting predominantly eosinophils, lympho-
cytes, plasma cells, palisading macrophages and 
giant cells have been described in cases of VLST 
of both first-generation [4, 5] and second-gen-
eration DES [6]. These inflammatory infiltrates 
could be observed in the stented vessel wall 
[4, 6], but also in the harvested thrombus [5]. 
A granulocytic infiltrate rich in eosinophils is 
more often observed in sirolimus-eluting stents 
than in paclitaxel-eluting stents undergoing 
VLST [5]. Nonetheless, instead of this profuse 
eosinophilic infiltrate, the current case shows 
scarce neutrophilic presence in the aspirated 
thrombus, that cannot be properly considered an 
inflammatory infiltrate. It might quantitatively 
correspond to the circulating granulocytes that 
get trapped in the thrombus mesh during its for-
mation, thus suggesting a different pathogenesis, 
with negligible role of inflammation. 
Furthermore, the stent thrombosis in the cur-
rent case can hardly be explained by the properties 
of the DES, because the thrombus originates from 
the second-generation DES (Xience, Abbott vascular, 
Santa Clara, CA), which has a more biocompatible 
and hemocompatible profile than the first-generation 
paclitaxel-eluting stent (Taxus, Boston Scientific, 
Natick, MAD, USA). The paradoxal occurrence of 
VLST against aprioristic probability in the most 
hemocompatible DES highlights the importance of 
the biomechanical factors, since the Taxus stent was 
optimally deployed and covered, whilst the Xience 
stent was severely distorted, as previously described.
The case offers a novel insight into the patho-
genesis of very late stent thrombosis, describing 
an additional mechanism insufficiently addressed 
in previous publications and confirming the throm-
botic propensity of mechanical factors, like malap-
position and jailing. Furthermore, the case illus-
trates also the instrumental role of OCT to tailor 
the therapy in cases of device failure, an indication 
currently accepted as IIa in current European So-
ciety of Cardiology guidelines. Finally, this case 
is the first scientific report pointing the ability of 
3D-OCT to identify the stent type whenever this 
information is missing.
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